tradingkey.logo
tradingkey.logo
Buscar

Clearpoint Neuro Inc

CLPT
Añadir a la lista de seguimiento
18.720USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
561.35MCap. mercado
PérdidaP/E TTM

Más Datos de Clearpoint Neuro Inc Compañía

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Información de Clearpoint Neuro Inc

Símbolo de cotizaciónCLPT
Nombre de la empresaClearpoint Neuro Inc
Fecha de salida a bolsaJul 03, 2019
Director ejecutivoBurnett (Joseph Michael)
Número de empleados115
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 03
Dirección120 S. Sierra Avenue
CiudadSOLANA BEACH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92075
Teléfono19499006833
Sitio Webhttps://www.clearpointneuro.com/
Símbolo de cotizaciónCLPT
Fecha de salida a bolsaJul 03, 2019
Director ejecutivoBurnett (Joseph Michael)

Ejecutivos de Clearpoint Neuro Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Clearpoint Neuro Inc?

Los cinco principales accionistas de Clearpoint Neuro Inc son: Mr. Joseph Michael Burnett

¿Cuántas instituciones poseen acciones de Clearpoint Neuro Inc (CLPT)?

A fecha de 2026Q1, 266 instituciones poseen acciones de Clearpoint Neuro Inc, con un valor de mercado combinado de aproximadamente 15.83M, lo que representa el 52.78% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1860542.00.

¿Cuál es la mayor fuente de ganancias de Clearpoint Neuro Inc?

El 2026Q1, el segmento empresarial Products: Functional neurosurgery generó la ganancia más alta para Clearpoint Neuro Inc, ascendiendo a 14.83M y representando el 40.12% de la ganancia total.